Maximising Impact: Prof Sir Tony Kouzarides' Lessons from a Career in Research & Start-ups
Join us for an inspiring evening with Prof Sir Tony Kouzarides, a world-renowned cancer and epigenetics researcher, and founder of several pioneering organisations:
Abcam – antibody company (acq. $5.6B)
Storm Therapeutics – clinical-stage first-in-class drug discovery company
Chroma Therapeutics – drug discovery vehicles
Milner Therapeutics Institute – bridging academia, start-ups, biotechs, and pharma
Vellos – venture builder founded to support UK scientists to build world-changing companies
Sir Tony will share personal lessons on ‘Maximising Impact’, drawing on his career at the intersection of science, entrepreneurship, and translational success.
This event is hosted by Vellos, where Tony serves as CEO, and Fifty Years, who've joined forces to inspire and empower more UK scientists and engineers to launch indispensable companies.
Fifty Years is an early-stage VC firm. At 50Y, the team have built deep tech companies themselves and published the Spinout Playbook, the ultimate guide to spin out of academia. Fifty Years have backed over 100 deep tech startups and helped them raise over $4.6B.
Everything the the 50Y team knows about deep tech entrepreneurship has been distilled into 5050, a free, 16-week programme to help great scientists and engineers become great founders. Register your interest for the next cohort, kicking off in September 2025.
Powered by the Advanced Research and Invention Agency (ARIA). Find our privacy policy here https://www.fiftyyears.com/privacy